Structural basis for protocadherin-1 recognition by New World hantaviruses
En palabras de los autores
Hantaviruses are rodent-borne pathogens that cause severe human disease for which no approved therapeutics are available. New World hantaviruses, including Andes virus (ANDV), use the cell-surface receptor protocadherin-1 (PCDH1) to enter host cells1. However, the structural basis of this interaction remains unclear. Here we describe the structure of PCDH1 bound to the ANDV spike at near-atomic resolution. PCDH1 asymmetrically engages a deep central pocket formed by four Gn protomers in the spike, explaining why only intact viral particles or soluble tetramers recognize it. Mutagenesis identified three Gn loops that shape the receptor-binding site and afford the transfer of PCDH1 binding from New World to Old World glycoproteins. Structural and functional analyses of four neutralizing antibodies revealed that they block receptor binding through two distinct mechanisms—occluding access to the PCDH1-binding site or sterically preventing receptor engagement. Together, these findings define the structural determinants of hantavirus–receptor recognition, reveal how a virus can mask its receptor-binding site by recessing it in a surface depression and how antibodies can counter this strategy, and provide a framework for the design of antiviral therapeutics targeting the hantavirus spike. The structure of PCDH1 bound to the ANDV spike defines the structural determinants of hantavirus–receptor recognition.
En palabras simples Resumen con IA
Los hantavirus del Nuevo Mundo como el virus Andes usan una proteína de superficie celular llamada protocadherina-1 para entrar en las células humanas. Los investigadores determinaron la estructura detallada de la protocadherina-1 unida a la proteína espiga del virus Andes. Cuatro anticuerpos neutralizantes bloquean esta interacción de dos maneras diferentes, ya sea bloqueando el bolsillo o impidiendo físicamente la unión del receptor. Estos hallazgos pueden ayudar a diseñar medicamentos antivirales que se dirijan a la proteína espiga del hantavirus.
Escrito por Kimi K2.5 usando solo el abstract de arriba. Jev verificó que cada oración esté respaldada por las oraciones del abstract que cita y eliminó las que no. Pasá el cursor por una oración para ver de dónde sale. Se eliminó 1 oración por no estar respaldada por el abstract.
Apareció: viernes, 23 de octubre. Nature. Revista con revisión por pares.